Frontiers P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers

P2Y12 Receptor Modulates Sepsis-Induced Inflammation

P2Y12 Receptor Modulates Sepsis-Induced Inflammation

PDF] Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial - The

PDF) Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types

PDF) Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

Metabolic symbiosis in pancreatic cancer

Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia

Frontiers Purinergic signaling: Diverse effects and therapeutic potential in cancer

Frontiers Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms